Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation

Cited by (613)

Items 301–400 of 613

  1. Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding
    Burgess, Abigail E., Kleffmann, Torsten, Mace, Peter D. · 2021 · Journal of Molecular Biology
  2. Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth
    Ya-nan Zhu, Xiaowen Gan, Fan Pan, Xiaotian Ni, Leslie Myatt, Wangsheng Wang, Kang Sun · 2022 · BMC Medicine
  3. FUS reads histone H3K36me3 to regulate alternative polyadenylation
    Junqi Jia, Haonan Fan, Xinyi Wan, Yuan Fang, Zhuoning Li, Yin Tang, Yanjun Zhang, Jun Huang, Fang Dong · 2024 · Nucleic Acids Research
  4. The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer
    Wenqian Yu, Xiaona Lin, Shuai Leng, Yiming Hou, Zhiqiao Dang, Shishan Xue, Na Li, Fengquan Zhang · 2024 · Translational Oncology
  5. Disabling leading and lagging strand histone transmission results in parental histones loss and reduced cell plasticity and viability
    Leonie Kollenstart, Alva Biran, Nicolás Alcaraz, Nazaret Reverón-Gómez, Victor Solis‐Mezarino, Moritz Carl Völker-Albert, Fiona Jenkinson, Valentin Flury, Anja Groth · 2025 · Science Advances
  6. H3K27me3 and the PRC1-H2AK119ub pathway cooperatively maintain heterochromatin and transcriptional silencing after the loss of H3K9 methylation
    Kei Fukuda, Chikako Shimura, Yoichi Shinkai · 2025 · Epigenetics & Chromatin
  7. PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome
    Kazumasa Aoyama, Daisuke Shinoda, Emi Suzuki, Yaeko Nakajima‐Takagi, Motohiko Oshima, Shuhei Koide, Ola Rizq, Sha Si, Shiro Tara, Goro Sashida et al. · 2020 · Leukemia
  8. Differential requirement for the Polycomb repressor complex 2 in dendritic cell and tissue-resident myeloid cell homeostasis
    Yifan Zhan, Yuxia Zhang, Shengbo Zhang, Hannah D. Coughlan, Pedro L. Baldoni, Nicolas Jacquelot, Wang H. J. Cao, Simon Preston, Cynthia Louis, Jai Rautela et al. · 2021 · Science Immunology
  9. Pancreas development and the Polycomb group protein complexes
    Niloufer P. Dumasia, Prasad S. Pethe · 2020 · Mechanisms of Development
  10. A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2
    Xin Liu · 2020 · Sub-cellular biochemistry/Subcellular biochemistry
  11. lncRNA RBM5‐AS1 promotes cell proliferation and invasion by epigenetically silencing miR‐132/212 in hepatocellular carcinoma cells
    Jin‐Yong Mu, Xiu‐Jun Tian, Ying‐Jie Chen · 2021 · Cell Biology International
  12. Low complexity domains, condensates, and stem cell pluripotency
    Munender Vodnala, Eun‐Bee Choi, Yick W. Fong · 2021 · World Journal of Stem Cells
  13. Long non-coding RNA HOTAIR regulates the stemness of breast cancer cells via activation of NF-κB signaling pathway
    Jiajia Wang, Xingzhu Liu, Ping Li, Junrong Wang, Yu Shu, Xinyu Zhong, Zhen Gao, Jingyi Yang, Yashuang Jiang, Geng Yang · 2022 · Research Square
  14. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma
    Lucas D. Caeiro, Yuichiro Nakata, Rodrigo L. Borges, Mengsheng Zha, Liliana Garcia-Martinez, Carolina P. Bañuelos, Stephanie Stransky, Tong Liu, Ho Lam Chan, John Brabson et al. · 2024 · Genes & Development
  15. Dominant-negative effects of Weaver syndrome-associated EZH2 variants
    Orla Deevy, Jingjing Li, Craig Monger, Francesca Matrà, Ellen Tuck, Molly Davies, Mihaly Badonyi, Maeve Boyce, Emma J. Doyle, Karsten Hokamp et al. · 2025 · Genes & Development
  16. Epigenetic preparation of future gene induction kinetics
    Xiong, Jun, Zhu, Bing · 2025 · Annual Review of Genetics
  17. Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress
    Teng Qiu, Yuanyuan Ding, Jingting Qin, Dexu Ren, Mengru Xie, Qilan Qian, Yasong Wang, Ling Ma, Aixin Jing, Jiayan Yang et al. · 2023 · Cellular Signalling
  18. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors
    Mehrdad Hashemi, Pouria Daneii, Mahya Asadalizadeh, Kiana Tabari, Arash Matinahmadi, Seyed Shahabadin Bidoki, Yasamin Sadat Mousavi Motlagh, Ali Moghadas Jafari, Amin Ghorbani, Amir Dehghanpour et al. · 2024 · The International Journal of Biochemistry & Cell Biology
  19. Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis
    Hongwei Zhang, Zixuan Wang, Xiaolong Qiao, Nan Peng, Jiaxing Wu, Yinan Chen, Chuandong Cheng · 2024 · Molecular Medicine
  20. scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes
    Justyna Jarczak, Kamila Bujko, Mariusz Z. Ratajczak, Magda Kucia · 2024 · Scientific Reports
  21. Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations
    Yanping Zeng, Jian Xiao, Li Shi, Yangsha Li, Yuanxin Xu, Jiayun Zhou, Xiao Dong, Haiyang Hou, Chao Zhong, Gang Cheng et al. · 2025 · European Journal of Medicinal Chemistry
  22. PRC1 and PRC2 proximal interactome in mouse embryonic stem cells
    Dick W. Zijlmans, Suzan Stelloo, Danique J. C. Bax, Yavor Yordanov, Pien Toebosch, Maximilian W.D. Raas, Sigrid Verhelst, Lieke A. Lamers, Marijke P. A. Baltissen, Pascal W.T.C. Jansen et al. · 2025 · Cell Reports
  23. An evolving landscape of PRC2–RNA interactions in chromatin regulation
    Rodrigo Aguilar, Michael Rosenberg, Vered Levy, Jeannie T. Lee · 2025 · Nature Reviews Molecular Cell Biology
  24. The Role of Methylation Modification in Neural Injury and Repair
    Saizhen Lv, Yanyu Pan, Tiemei Zheng, Qianqian Cao, Bin Yu, Feng‐Quan Zhou, Dong Wang · 2025 · International Journal of Molecular Sciences
  25. RNA-induced PRC2 inhibition depends on the sequence of bound RNA
    Jiarui Song, Liqi Yao, Anne R. Gooding, Valentin Thron, Wayne O. Hemphill, Karen J. Goodrich, Annette H. Erbse, Vignesh Kasinath, Thomas R. Cech · 2026 · Nature Communications
  26. Histone Methylation Is Required for Virulence, Conidiation, and Multi-Stress Resistance of Alternaria alternata
    Shuai Meng, Suya Huang, Jinhua Liu, Yunpeng Gai, Min Li, Shuo Duan, Shuting Zhang, Xuepeng Sun, Qi Yang, Yuchun Wang et al. · 2022 · Frontiers in Microbiology
  27. PHF1 compartmentalizes PRC2 via phase separation
    Genzhe Lu, Pilong Li · 2023 · Biochemical Journal
  28. An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants
    Bruce Nmezi, Guillermo Rodríguez Bey, Talia DeFrancesco Oranburg, Kseniia Dudnyk, Santana M. Lardo, Nathan Herdman, Anastasia M. Jacko, Sandy Rubio, Emanuel Loeza‐Alcocer, Julia Kofler et al. · 2025 · Nature Communications
  29. Depletion of Demethylase KDM6 Enhances Early Neuroectoderm Commitment of Human PSCs
    Yajing Meng, Tianzhe Zhang, Ran Zheng, Song Ding, Jie Yang, Ran Liu, Yingan Jiang, Wei Jiang · 2021 · Frontiers in Cell and Developmental Biology
  30. Structural insights into the interactions of Polycomb Repressive Complex 2 with chromatin
    Akhil Gargey, Liqi Yao, Vignesh Kasinath · 2021 · Biochemical Society Transactions
  31. Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression
    Kaiji Xie, Jingxin Zeng, Liming Wen, Xin Peng, Zhibin Lin, Gaopeng Xian, Yuyang Guo, Xi Yang, Peixin Li, Dingli Xu et al. · 2022 · Atherosclerosis
  32. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
    Ugo Chianese, Chiara Papulino, Wout Megchelenbrink, Francesco Paolo Tambaro, Fortunato Ciardiello, Rosaria Benedetti, Lucia Altucci · 2023 · Seminars in Cancer Biology
  33. DOT1L interaction partner AF10 controls patterning of H3K79 methylation and RNA polymerase II to maintain cell identity
    Coral K. Wille, Edwin N. Neumann, Aniruddha J. Deshpande, Rupa Sridharan · 2023 · Stem Cell Reports
  34. Emerging interactions between RNA methylation and chromatin architecture
    Amber Louwagie, Ly Vu · 2024 · Current Opinion in Genetics & Development
  35. Epigenetic targets and their inhibitors in the treatment of idiopathic pulmonary fibrosis
    Xiaohui Miao, Pan Liu, Yangyang Liu, Wenying Zhang, Chunxin Li, Xiujiang Wang · 2025 · European Journal of Medicinal Chemistry
  36. Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markers
    Chien-Chu Lin, Yani Zhao, Caroline A. Foley, Aspen T. Hawkins, Lindsey Ingerman James, Stephen V. Frye, Robert K. McGinty · 2025 · Molecular Cell
  37. High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
    Christopher L. Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, Andrew F. Teich et al. · 2025 · Journal of Neuroinflammation
  38. Role of EZH2 in adipogenesis and obesity: Current state of the art and implications – A review
    Haixia Wang · 2022 · Medicine
  39. A cis-regulatory module underlies retinal ganglion cell genesis and axonogenesis
    Kamakshi Mehta, Marwa Daghsni, Reza Raeisossadati, Zhongli Xu, Emily Davis, Abigail Naidich, Bingjie Wang, Shiyue Tao, Shaohua Pi, Wei Chen et al. · 2024 · Cell Reports
  40. WTAP-dependent N6-methyladenosine methylation of lncRNA TEX41 promotes renal cell carcinoma progression
    Zhenwei Zhou, Xianjiong Chen, Huan Wang, Lifeng Ding, Mingchao Wang, Gonghui Li, Liqun Xia · 2024 · Scientific Reports
  41. Heterochromatin and Polycomb as regulators of haematopoiesis
    Christine R. Keenan · 2021 · Biochemical Society Transactions
  42. Getting under the skin of Polycomb-dependent gene regulation
    Neil P. Blackledge, Robert J. Klose · 2021 · Genes & Development
  43. Cyclohexene oxide CA, a derivative of zeylenone, exhibits anti-cancer activity in glioblastoma by inducing G0/G1 phase arrest through interference with EZH2
    Rui Jun Su, Weiwei Cao, Guoxu Ma, Weiping Li, Zongyang Li, Yongpei Liu, Lei Chen, Zebin Chen, Xuejuan Li, Ping Cui et al. · 2024 · Frontiers in Pharmacology
  44. The dual functionality of EZH2 in cardiovascular disease: Bridging cancer biology and cardiac pathophysiology through epigenetic regulation, metabolic reprogramming, and novel therapeutic interventions
    Shengwei Fang, Faris Alrumaihi, Wanian M Alwanian, Hajed Obaid Alharbi, Nujud Ahmed Alnughymishi, Somayah Mohammad Alfifi, Elizabeth S. Bennett, Peipei Zhang · 2025 · Current Problems in Cardiology
  45. Niche-specific epigenetic interventions in the spatially heterogeneous glioblastoma microenvironmental landscape: strategies for radiotherapy enhancement
    Junjie Wang, Kunjie Li, Yongzhe Wang, Junyi Zhang, Xin Peng, Ning Ji · 2025 · Frontiers in Molecular Biosciences
  46. Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3
    Bolin Chen, Chengcheng Dong, Fang Wang, Jiacai Wu · 2021 · OncoTargets and Therapy
  47. H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs
    Brian Krug, Bo Hu, Haifeng Chen, Claudia Negrón-Lomas, Xiao Chen, Ahmed El Mouatani, Kristjan H. Gretarsson, Adam Ptack, Shriya Deshmukh, Nisha Kabir et al. · 2026 · Nature Genetics
  48. Recent research progress of circular RNAs in hepatocellular carcinoma
    Zhi-di Li, Yang-ling Li, Jing Lu, Shang Liang, Chong Zhang, Linghui Zeng · 2024 · Frontiers in Oncology
  49. Transcriptionally active chromatin loops contain both ‘active’ and ‘inactive’ histone modifications that exhibit exclusivity at the level of nucleosome clusters
    Stefan A. Koestler, Madeleine L. Ball, Leila Mureşan, Vineet Dinakaran, Robert A. White · 2024 · Epigenetics & Chromatin
  50. Epigenetic insights into Fragile X Syndrome
    Liangqun Xie, Huiying Li, MengLiang Xiao, Ningjing Chen, Xiaoxiao Zang, Yingying Liu, Hong Ye, Chaogang Tang · 2024 · Frontiers in Cell and Developmental Biology
  51. PRC2-RNA interactions: Viewpoint from Jimmy K. Guo, Mario R. Blanco, and Mitchell Guttman
    Jimmy K. Guo, Mario R. Blanco, Mitchell Guttman · 2024 · Molecular Cell
  52. PRC1 suppresses a female gene regulatory network to ensure testicular differentiation
    So Maezawa, Masashi Yukawa, Kazuteru Hasegawa, Ryo Sugiyama, Mizuho Iizuka, Mengwen Hu, Akihiko Sakashita, Miguel Vidal, Haruhiko Koseki, Artem Barski et al. · 2023 · Cell Death and Disease
  53. Untangling the gordian knot: The intertwining interactions between developmental hormone signaling and epigenetic mechanisms in insects
    Bart Geens, Stijn Goossens, Jia Li, Yves Van de Peer, Jozef Vanden Broeck · 2024 · Molecular and Cellular Endocrinology
  54. Reduced Heterochromatin Formation on the pFAR4 Miniplasmid Allows Sustained Transgene Expression in the Mouse Liver
    Marie Pastor, Mickaël Quiviger, Julie Pailloux, Daniel Scherman, Corinne Marie · 2020 · Molecular Therapy — Nucleic Acids
  55. Epigenetic regulation of T cells by Polycomb group proteins
    Guilherme A. Melo, Carolina Calôba, Gabrielle Brum, Thaís O Passos, Gustavo Martínez, Renata M. Pereira · 2022 · Journal of Leukocyte Biology
  56. Polycomb Repressive Complex 2: a Dimmer Switch of Gene Regulation in Calvarial Bone Development
    Timothy E Nehila, James W. Ferguson, Radhika P. Atit · 2020 · Current Osteoporosis Reports
  57. Human Telomerase Expression is under Direct Transcriptional Control of the Telomere-binding-factor TRF2
    Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Heterochromatin in the fungal plant pathogen, Zymoseptoria tritici: Control of transposable elements, genome plasticity and virulence
    Callum J. Fraser, Simon K. Whitehall · 2022 · Frontiers in Genetics
  59. Maternal high fat diet induces circadian clock-independent endocrine alterations impacting the metabolism of the offspring
    Lu Ding, Benjamin Dieter Weger, J. Y. Liu, Liyuan Zhou, Yenkai Lim, Dongmei Wang, Ziyan Xie, Jing Liu, Jing Ren, Jia Zheng et al. · 2024 · iScience
  60. Histone modifications in development
    Yuhao Liu, Robert Schneider · 2025 · Development
  61. Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study
    Zhengfu Fan, Jin Wang, Dan Liu, Lin Shen, Meiyu Fang, Patrick Johnson, Han Tun, David Sommerhalder, Jilong Yang, Yun Sik Yang et al. · 2025 · EClinicalMedicine
  62. Unraveling epigenetic drivers of immune evasion in gliomas: mechanisms and therapeutic implications
    Dan Wu, Dongen Ju, Yujia Zhao, Wenna Liu, Qingqing Liu, Ying Jie Liang · 2025 · Frontiers in Immunology
  63. Epigenetic‑ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review)
    Ying Zhu, Zhixin Hu, Jianshuo Liu, Huaqing Duan, Jiqiang Zeng, Xiaosheng Li, Yang Tang, Ziling Song, Zhipeng Wu, Shanrong Zhang et al. · 2025 · International Journal of Molecular Medicine
  64. EZHIP restricts noncanonical PRC2 binding and regulates H3K27me3 intergenerational inheritance and reprogramming
    Yitian Zeng, Feng Kong, Zihan Xu, Xukun Lu, Qian Li, Bofeng Liu, Shu Liu, Lijun Dong, Ling Liu, Wenying Wang et al. · 2025 · Cell stem cell
  65. The Dynamics of Chromatin Replication
    Leonie Kollenstart, Sebastian Jespersen Charlton, Anja Groth · 2026 · Annual Review of Biochemistry
  66. Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer
    Yi Zhang, Bihui Zheng, Kexin Lou, Xinyu Xu, Youtao Xu · 2022 · Annals of Diagnostic Pathology
  67. SNIP1 and PRC2 coordinate cell fates of neural progenitors during brain development
    Yurika Matsui, Mohamed Nadhir Djekidel, Katherine Lindsay, Parimal Samir, Nina Connolly, Gang Wu, Xiaoyang Yang, Yiping Fan, Beisi Xu, Jamy C. Peng · 2023 · Nature Communications
  68. Selective requirement for polycomb repressor complex 2 in the generation of specific hypothalamic neuronal subtypes
    Behzad Yaghmaeian Salmani, Brad Balderson, Susanne Bauer, Helen Ekman, Annika Starkenberg, Thomas Perlmann, Michael Piper, Mikael Bodén A, Stefan Thor · 2022 · Development
  69. Long non-coding RNAs - SNHG6 emerge as potential marker in colorectal cancer
    Michalina Jurkiewicz, Adrian Szczepaniak, Marta Zielińska · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  70. Upregulated Long Non-Coding RNA LL22NC03-N64E9.1 Promotes the Proliferation and Migration of Human Breast Cancer Cells by Silencing Kruppel-Like Factor 2 Expression
    Weibin Lian, Xiaohua Jiang, Liangqiang Li, Qinglan Wang, Chengye Hong, Peidong Yang, Debo Chen · 2020 · Cancer Management and Research
  71. Structural classification of EZH2 inhibitors and prospects for the treatment of tumor: a review
    Ling Yu, Ming-tao Xia, Youde Wang, Zhiwei Yan, Liying Zhang, Shuai Li · 2023 · Medicinal Chemistry Research
  72. Polycomb repression of Hox genes involves spatial feedback but not domain compaction or demixing
    Sedona E. Murphy, Alistair Nicol Boettiger · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Sparse CBX2 nucleates many Polycomb proteins to promote facultative heterochromatinization of Polycomb target genes
    Steven Ingersoll, Abby Trouth, Xinlong Luo, Axel Espinoza, Joey Wen, Joseph C. Tucker, Kalkidan Astatike, Christopher J. Phiel, Tatiana G. Kutateladze, Tao Wu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  74. USP17L promotes the 2-cell-like program through deubiquitination of H2AK119ub1 and ZSCAN4
    Panpan Shi, Xukun Lu, Kairang Jin, Linlin Liu, Guoxing Yin, Wenying Wang, Lijuan Wang, Lijuan Wang, Lijun Dong, Wei Xie et al. · 2025 · Nature Communications
  75. Epigenetic Dysregulation in Neurodegenerative Disease: Implications for Neuropathology and Therapy
    Hussein Qasim, Karis Khattab, Mohammad Abu Shugaer, Giustino Varrassi · 2025 · Cureus
  76. Polycomb repressive complexes 1 and 2 independently and dynamically regulate euchromatin during cerebellar neurodevelopment
    Aditya Parmar, Anjali Srinivasan, Lena Krockenberger, Abijith Augustine, Owin Gong, Addison C. Bullard, Riya Kalra, Leya Ledvin, Dylan A. Pilz, Jonathan Tawil et al. · 2025 · PLoS Genetics
  77. PLETHORA transcription factors orchestrate epigenetic silencing of bivalent chromatin to promote root meristem development in rice
    Qi Li, Junjie Li, Xintian Tang, Chen Chu, Jing Wang, Dao‐Xiu Zhou, Yu Zhao · 2025 · Molecular Plant
  78. Epigenetic enzyme inhibitors targeting DNA, histone, and RNA methylation: Mechanisms and therapeutic applications in cancer
    Yiman Wang, Chen Ma, Xinya Liu, Junkai Cheng, Dan Zhu, Peng Liu, Peng Qi, Xiankai Li, Jian Gu, Qin Wang · 2026 · European Journal of Medicinal Chemistry
  79. Histone modification cross-talk: analytical tools and molecular mechanisms
    Jennifer Jiang, Sarah E. DuBois-Coyne, Eunju Nam, Samuel D. Whedon, Kwangwoon Lee, Philip A. Cole · 2026 · Biochemical Journal
  80. H3F3A K27M Mutation Promotes the Infiltrative Growth of High-Grade Glioma in Adults by Activating β-Catenin/USP1 Signaling
    Zhiyuan Sun, Yufu Zhu, Xia Feng, Xiaoyun Liu, Kunlin Zhou, Qing Wang, Hengzhu Zhang, Hengliang Shi · 2022 · Cancers
  81. Sequential deregulation of histone marks, chromatin accessibility and gene expression in response to PROTAC-induced degradation of ASH2L
    Mirna Barsoum, Roksaneh Sayadi-Boroujeni, Alexander T. Stenzel, Philip Bussmann, Juliane Lüscher‐Firzlaff, Bernhard Lüscher · 2023 · Scientific Reports
  82. Covalent inhibitors meet epigenetics: New opportunities
    Qiang Feng, Luoting Yu, Lu Li, Qiangsheng Zhang · 2024 · European Journal of Medicinal Chemistry
  83. Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma
    Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer‐Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M. Melnick et al. · 2025 · PLoS Biology
  84. Epigenetic Therapies in Endocrine-Related Cancers: Past Insights and Clinical Progress
    Dhruvika Varun, Maria Haque, Jorja Jackson-Oxley, Rachel Thompson, Amber A. Kumari, Corinne L. Woodcock, Anna E. Harris, Srinivasan Madhusudan, Emad A. Rakha, Catrin Sian Rutland et al. · 2025 · Cancers
  85. EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma
    Lynnette Koh, Qing You Pang, Wisna Novera, See Wee Lim, Yuk Kien Chong, Jinyue Liu, Samantha Ya Lyn Ang, Ron Weng Yee Loh, Huilin Shao, Jianhong Ching et al. · 2024 · Neuro-Oncology
  86. Suppression of the H3K27me3 demethylase disrupts diapause formation in mosquito Culex pipiens
    Xueyan Wei, Prabin Dhungana, Kaylah Callender, Berhanu W. Zewde, Fu Chen, Sung Joon Kim, Cheolho Sim · 2024 · Insect Biochemistry and Molecular Biology
  87. Molecular mechanisms underlying the evolution of a color polyphenism by genetic accommodation in the tobacco hornworm, Manduca sexta
    Yuichiro Suzuki, Stephanie Amaya, Paula González, Daniela Becerril, Surisadai Aquit, Maya Davis, Madeline Hoesel, Elizabeth Chou, Hesper Khong, Kathryn Zaia et al. · 2025 · Proceedings of the National Academy of Sciences
  88. P14AS upregulates gene expression in the CDKN2A/2B locus through competitive binding to PcG protein CBX7
    Zhuoqi Li, Juanli Qiao, Wanru Ma, Jing Zhou, Liankun Gu, Dajun Deng, Baozhen Zhang · 2022 · Frontiers in Cell and Developmental Biology
  89. UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease
    Ola Rizq, Naoya Mimura, Motohiko Oshima, Shuji Momose, Naoya Takayama, Naoki Itokawa, Shuhei Koide, Asuka Shibamiya, Yurie Miyamoto‐Nagai, Mohamed Rizk et al. · 2023 · Leukemia
  90. Evidence that AGL17 is a significant downstream target of CLF in floral transition control
    Jie Shu, Chen Chen, Susanne E. Kohalmi, Yuhai Cui · 2020 · Plant Signaling & Behavior
  91. RNA closing the Polycomb circle
    Ivano Mocavini, Luciano Di Croce · 2020 · Nature Genetics
  92. Sight restored by turning back the epigenetic clock
    Andrew D. Huberman · 2020 · Nature
  93. Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer
    Mohd Danishuddin, Vikas Kumar, Shraddha Parate, Ashutosh Bahuguna, Gihwan Lee, Myeong Ok Kim, Keun Woo Lee · 2021 · Pharmaceuticals
  94. Zebrafish Polycomb repressive complex-2 critical roles are largely Ezh2- over Ezh1-driven and concentrate during early embryogenesis
    Gabriel A. Yette, Scott Stewart, Kryn Stankunas · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Histone modification cross-talk and protein complex diversification confer plasticity to Polycomb repression
    Jacques Bonnet, Eva Triantopoulou, Jasmin Birnhäupl, Chenggang Lu, Margaret T. Fuller, Jürg Müller · 2025 · Genes & Development
  96. Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook
    Lv, Liang-Zhen, Wang, Zhao-Di, Ren, Jia-jie, Li, Lu-Hao, Liu, Xian-bao, Li, Jia-li, Zhu, Hui, Jiang, Bei, Han, Ya-peng, Zhou, Xue-ming et al. · 2026 · Frontiers in Genetics
  97. Noncanonical association of EZH2 with E2F1 promotes tumor proliferation through chromatin remodeling
    Mijoung Yoo, Hyeonji Lee, Hyorim Park, Byunghee Kang, Hyo‐Min Kim, Tae-Kyung Kim, Tae‐Young Roh · 2025 · Experimental & Molecular Medicine
  98. Changes in histone abundance and post-translational modifications in Rana [Lithobates] catesbeiana tissues during temperature-mediated thyroid hormone-induced metamorphosis
    Haley N. Kuecks-Winger, Anita A. Thambirajah, Lorissa M. Corrie, Caren C. Helbing · 2025 · Comparative Biochemistry and Physiology Part D Genomics and Proteomics
  99. CRISPR ‐Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl‐fumarate‐induced cell death
    Jan-Peter Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, E Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein et al. · 2025 · FEBS Journal
  100. Epigenetics Role in Spermatozoa Function: Implications in Health and Evolution—An Overview
    Julia Andreu-Noguera, Andrea López-Botella, Paula Sáez‐Espinosa, María José Gómez‐Torres · 2023 · Life